Cost-effectiveness of particle therapy: Current evidence and future needs
- 1 November 2008
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 89 (2) , 127-134
- https://doi.org/10.1016/j.radonc.2008.07.015
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? NoRadiotherapy and Oncology, 2008
- Randomized controlled trials in health technology assessment: Overkill or overdue?Radiotherapy and Oncology, 2008
- Should Randomized Clinical Trials Be Required for Proton Radiotherapy?Journal of Clinical Oncology, 2008
- A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancerRadiotherapy and Oncology, 2007
- Proton beam therapy – Do we need the randomised trials and can we do them?Radiotherapy and Oncology, 2007
- Proton therapy – A systematic review of clinical effectivenessRadiotherapy and Oncology, 2007
- Proton Therapy in Clinical Practice: Current Clinical EvidenceJournal of Clinical Oncology, 2007
- Think Globally, Act LocallyJournal of Clinical Oncology, 2007
- Valorisation de la radiothérapie de haute technologie en EuropeCancer/Radiothérapie, 2006
- Number of patients potentially eligible for proton therapyActa Oncologica, 2005